<DOC>
	<DOCNO>NCT02306226</DOCNO>
	<brief_summary>Post-market registry aim evaluate safety performance ACURATE neo™ Aortic Bioprosthesis ACURATE TF™ Transfemoral Delivery System patient severe aortic stenosis treat commercialized device</brief_summary>
	<brief_title>Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry</brief_title>
	<detailed_description>The SAVI TF single arm , multicenter , non-randomized open registry . The purpose registry collect monitor ongoing safety performance data commercial use ACURATE neo™ Aortic Bioprosthesis ACURATE TF™ Transfemoral Delivery System . The ACURATE neo™ Transfemoral Delivery System intend use minimally invasive , transcatheter aortic valve replacement ( TAVR ) use transfemoral access patient present severe aortic valve stenosis . The primary objective evaluate safety performance ACURATE neo™ Aortic Bioprosthesis ACURATE TF™ Transfemoral Delivery System first 1000 consecutive patient severe aortic stenosis treat newly market device . The secondary objective evaluate adverse event device performance newly market device .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Patient include registry eligible transcatheter treatment severe aortic stenosis ACURATE neo™ Aortic Bioprosthesis ACURATE TF™ Transfemoral Delivery System per Instructions Use 2 . Patient willing participate study , provide sign Informed Consent/Data Authorization Form authorize share data registry 3 . The subject treating physician agree subject return require postprocedure followup visit 1 . Patients exclude registry eligible transcatheter treatment severe aortic stenosis ACURATE neo™ Aortic Bioprosthesis ACURATE TF™ Transfemoral Delivery System per Instructions For Use .</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>TAVI</keyword>
	<keyword>Aortic stenosis</keyword>
	<keyword>Transcatheter aortic valve replacement</keyword>
	<keyword>Transcatheter aortic valve implantation</keyword>
	<keyword>Transfemoral access</keyword>
</DOC>